BioCardia, Inc.
BCDA
$1.14
$0.043.64%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -100.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -100.00% |
| Cost of Revenue | -20.28% | 0.54% | 71.00% | 23.29% | 22.40% |
| Gross Profit | 20.28% | -0.54% | -71.64% | -29.01% | -23.80% |
| SG&A Expenses | -2.32% | -33.09% | -19.84% | 9.83% | -3.72% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -13.27% | -15.26% | 24.15% | 17.00% | 10.68% |
| Operating Income | 13.27% | 15.26% | -24.38% | -19.82% | -11.37% |
| Income Before Tax | 13.59% | 14.62% | -24.48% | -19.63% | -10.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 13.59% | 14.62% | -24.48% | -19.63% | -10.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 13.59% | 14.62% | -24.48% | -19.63% | -10.81% |
| EBIT | 13.27% | 15.26% | -24.38% | -19.82% | -11.37% |
| EBITDA | 12.84% | 14.71% | -25.37% | -20.30% | -11.72% |
| EPS Basic | 62.88% | 61.55% | 53.81% | 56.76% | 63.72% |
| Normalized Basic EPS | 62.88% | 61.56% | 53.82% | 56.76% | 63.72% |
| EPS Diluted | 62.88% | 61.55% | 53.81% | 56.76% | 63.72% |
| Normalized Diluted EPS | 62.88% | 61.56% | 53.82% | 56.76% | 63.72% |
| Average Basic Shares Outstanding | 132.73% | 122.03% | 169.55% | 176.68% | 205.47% |
| Average Diluted Shares Outstanding | 132.73% | 122.03% | 169.55% | 176.68% | 205.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |